Home / Drugs / latanoprostene bunod

latanoprostene bunod

FDA Drug Profile — Vyzulta

Drug Details

Generic Name
latanoprostene bunod
Brand Names
Vyzulta
Application Number
NDA207795
Sponsor
Bausch & Lomb Incorporated
NDC Codes
1
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients
LATANOPROSTENE BUNOD

Indications and Usage

1 INDICATIONS AND USAGE VYZULTA ® (latanoprostene bunod ophthalmic solution) 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. VYZULTA is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )